CNCR vs. EWK ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to iShares MSCI Belgium Capped Investable Market Index Fund (EWK)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$15.80
Average Daily Volume
3,704
67
EWK
iShares MSCI Belgium Capped Investable Market Index Fund
EWK Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the MSCI Belgium IMI 25/50 Index (the "underlying index"). The fund will at all times invest at least 80% of its assets in the securities of its underlying index and in depositary receipts ("DRs") representing securities in its underlying index. The underlying index is designed to measure broad-based equity market performance in Belgium. The fund is non-diversified.Grade (RS Rating)
Last Trade
$19.83
Average Daily Volume
10,397
3
Performance
Period | CNCR | EWK |
---|---|---|
30 Days | 7.26% | -2.05% |
60 Days | 11.42% | -2.00% |
90 Days | 15.08% | 2.14% |
12 Months | 52.07% | 15.83% |
0 Overlapping Holdings
Symbol | Grade | Weight in CNCR | Weight in EWK | Overlap |
---|
CNCR Overweight 67 Positions Relative to EWK
Symbol | Grade | Weight | |
---|---|---|---|
GLUE | C | 2.16% | |
GNLX | D | 1.72% | |
RVMD | B | 1.69% | |
EXEL | A | 1.69% | |
ELVN | B | 1.68% | |
RAPT | D | 1.62% | |
KPTI | D | 1.61% | |
REPL | B | 1.55% | |
IOVA | C | 1.55% | |
HCM | C | 1.54% | |
MGNX | D | 1.54% | |
BMEA | F | 1.54% | |
YMAB | C | 1.54% | |
ACLX | A | 1.52% | |
JANX | C | 1.49% | |
BMY | B | 1.48% | |
CRBU | D | 1.48% | |
RPTX | D | 1.47% | |
ARVN | C | 1.46% | |
DAWN | C | 1.46% | |
BPMC | C | 1.43% | |
SNDX | C | 1.42% | |
IGMS | D | 1.4% | |
AURA | B | 1.39% | |
MRUS | B | 1.37% | |
XNCR | C | 1.37% | |
ALLO | C | 1.34% | |
ACRV | C | 1.33% | |
KYMR | B | 1.31% | |
STRO | C | 1.31% | |
IMCR | D | 1.31% | |
NRIX | B | 1.31% | |
RXRX | D | 1.31% | |
ERAS | B | 1.31% | |
GERN | D | 1.28% | |
CGEM | F | 1.27% | |
MRSN | D | 1.26% | |
TSVT | C | 1.25% | |
RCUS | D | 1.25% | |
BCYC | C | 1.24% | |
ZNTL | F | 1.23% | |
BNTX | D | 1.23% | |
LYEL | F | 1.23% | |
SDGR | D | 1.23% | |
FHTX | C | 1.22% | |
AUTL | D | 1.19% | |
MRK | F | 1.18% | |
LEGN | F | 1.18% | |
SWTX | F | 1.17% | |
GMAB | F | 1.16% | |
ACET | F | 1.14% | |
IPHA | F | 1.13% | |
TYRA | F | 1.11% | |
PGEN | D | 1.11% | |
KURA | F | 1.1% | |
VOR | F | 1.09% | |
NUVL | D | 1.08% | |
IDYA | F | 1.06% | |
NUVB | D | 1.02% | |
REGN | F | 1.0% | |
IMTX | F | 1.0% | |
ITOS | F | 0.99% | |
RLAY | F | 0.98% | |
IMRX | F | 0.89% | |
SMMT | C | 0.88% | |
FATE | F | 0.84% | |
PRLD | F | 0.65% |
CNCR: Top Represented Industries & Keywords
EWK: Top Represented Industries & Keywords